OTCPicks.com Daily Market Movers Digest Midday Report for Thursday, March 19th PTEK, QMCI, ADDE, XTNT, XTLB, ARM

Our Stocks to Watch today include PokerTek Inc. (Nasdaq: PTEK), QuoteMedia Inc. (OTCBB: QMCI), Adoodle Inc. (OTC: ADDE), XTENT Inc. (Nasdaq: XTNT), XTL Biopharmaceuticals Ltd. (Nasdaq: XTLB) and ArvinMeritor Inc. (NYSE: ARM).

POKERTEK INCORPORATED (NASDAQ: PTEK)

"Up 69.01% in morning trading"

PokerTek, Inc., headquartered in Matthews, NC, develops and markets products for the casino and amusement industries. PokerTek developed PokerPro automated poker tables and related software applications to increase casino revenue, reduce expenses and attract new players into poker rooms by offering interactive poker that is fast, fun and mistake-free. Heads-Up Challenge is a two-player table that allows bars and restaurant patrons to compete head-to-head in various games for amusement purposes, increases earnings for game operators and provides patrons unique and challenging on-site entertainment. Both products are installed worldwide.

QUOTEMEDIA INCORPORATED (OTCBB: QMCI)

QuoteMedia, Inc. is a leading software developer and provider of real-time streaming financial market information, decision-support, news and research solutions to brokerage, financial services companies, business and media corporations. Among its many leading-edge products lines, the Company offers data feeds, news, dynamic market content solutions, interactive stock research tools, financial applications and real-time wireless applications. QuoteMedia provides data and services for companies such as the NASDAQ, the OTCBB, Dow Jones & Company, Forbes.com, Scotia Capital, Business Wire, Southwest Securities, Regal Securities, FBR Direct, Broadridge Financial Solutions, Inc., AIM Trimark, Zacks Investment Research, ChoiceTrade, QTrade, Schaeffer's Investment Research, Automated Financial Systems, WallStreet*E, and others. For more information, visit www.quotemedia.com.

ADOODLE INCORPORATED (OTC: ADDE)

The NOXO Division of Adoodle focuses on Olfaction Perception Altering — Stimulation and Inhibition. Adoodle presently has several NOXO Olfactory Perception Inhibition products. One is a petrolatum based gel version of NOXO, and the other is a Soy based NOXO cream that is easily absorbed into the skin. NOXO effectively inhibits offensive odor perception within the brain rather than just trying to artificially mask odors. The gel or cream is applied under the nostrils from a small one-time use packet and has a myriad of different vertical market applications. If you work in an environment where you are enduring noxious odors, you should try NOXO.

XTENT INCORPORATED (NASDAQ: XTNT)

"Up 57.78% in morning trading"

XTENT, Inc. is a medical device company focused on developing and commercializing innovative customizable drug eluting stent (DES) systems for the treatment of coronary artery disease (CAD). CAD is the most common form of cardiovascular disease and the number one cause of death in the United States and Europe. XTENT Custom NX DES Systems are designed to enable the treatment of single lesions, long lesions and multiple lesions of varying lengths and diameters, in one or more arteries with a single device.

XTL BIOPHARMACEUTICALS LIMITED (NASDAQ: XTLB)

"Up 60.49% in morning trading"

XTL Biopharmaceuticals, Ltd., a biopharmaceutical company, engages in the acquisition and development of therapeutics for the treatment of diabetic neuropathic pain and HCV. Its lead compound, Bicifadine, is a serotonin and norepineprine reuptake inhibitor, which is in Phase 2b clinical trial for the treatment of diabetic neuropathic pain, a chronic condition resulting from damage to peripheral nerves. The company's other development program, Diversity Oriented Synthesis, is focused on the development of novel pre-clinical hepatitis C small molecule inhibitors. XTL Biopharmaceuticals has strategic alliances with DOV, VivoQuest, and Presidio. The company was founded in 1993 as Xenograft Technologies, Ltd. and changed its name to XTL Biopharmaceuticals, Ltd. in 1995. XTL Biopharmaceuticals is headquartered in Valley Cottage, New York.

ARVINMERITOR INCORPORATED (NYSE: ARM)

"Up 30.53% in morning trading"

ArvinMeritor, Inc. is a premier global supplier of a broad range of integrated systems, modules and components to the motor vehicle industry. The company marks its centennial anniversary in 2009, celebrating a long history of 'forward thinking.' ArvinMeritor serves commercial truck, trailer and specialty original equipment manufacturers and certain aftermarkets, and light vehicle manufacturers.

About OTCPicks.com

Forward-Looking Statement: This press release includes "forward-looking statements" within the meaning of the federal securities laws, commonly identified by such terms as "believes," "looking ahead," "anticipates," "estimates" and other terms with similar meaning. Although the Company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can give no assurance that these assumptions will prove to be correct. Important factors that could cause actual results to differ materially from the Company's projections and expectations are disclosed in the Company's filings with the Securities and Exchange Commission. All forward-looking statements in this press release are expressly qualified by such cautionary statements and by reference to the underlying assumptions.

Disclosure: OTCPicks.com is being compensated via a services swap with QuoteMedia for QMCI advertising and promotional services. OTCPicks.com has been compensated sixty four thousand free trading shares from a non-controlling third party for ADDE advertising and promotional services.

OTCPicks.com is not a registered investment advisers or broker/dealer. OTCPicks.com makes no recommendation that the purchase of securities of companies profiled in this website is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk.